Cardiometabolic benefits Both tirzepatide and retatrutide have demonstrated improvements in various cardiometabolic risk factors, such as blood pressure, lipid profiles, and glycemic control
Tirzepatide is a medication that activates two important hormone receptors: GLP-1 (glucagon-like peptide-1) GIP (glucose-dependent insulinotropic polypeptide) These hormones help regulate: appetite, insulin response, digestion, satiety, blood sugar balance, and energy intake
Ding EL, Song Y, Malik VS, Liu S
*** Inno Supps burst onto the scene in 2019 and has fast become the market leader in weight maintenance and health supplements
The growing market for effective weight loss drugs is significant and expanding, creating opportunities for investors
Understanding Your Genetic Response to GLP-1 Medications Individual responses to semaglutide vary based on genetic factors affecting how your body processes GLP-1 signals